Clinical Trial Update: Evaluating The Roles of Novel Inflammatory Markers Compared to MCP-1 in Type 2 Diabetic Nephropathy

View source ↗

Summary

This document outlines a protocol to evaluate novel inflammatory markers and MCP-1 in Type 2 diabetic nephropathy. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Snippet

Sponsor: Assiut University | Conditions: Diabetic Nephropathy | Status: NOT_YET_RECRUITING